Potential Biological Weapons Threats

by Mark G. Kortepeter, Gerald W. Parker
Published 1999-08-01

Marburg virus disease: A summary for clinicians

by Mark G. Kortepeter, Kerry Dierberg, Erica S. Shenoy, Theodore J. Cieslak
Published 2020-10-01

Laboratory Exposures to Staphylococcal Enterotoxin B

by Janice M. Rusnak, Mark G. Kortepeter, Robert Ulrich, Mark Poli, Ellen Boudreau
Published 2004-09-01

A Methodology for Determining Which Diseases Warrant Care in a High-Level Containment Care Unit

by Theodore J. Cieslak, Jocelyn J. Herstein, Mark G. Kortepeter, Angela L. Hewlett
Published 2019-08-01

Fulminant Supraglottitis from Neisseria meningitidis

by Mark G. Kortepeter, Brian L. Adams, Wendell D. Zollinger, Robert A. Gasser
Published 2007-03-01

Comment on “Ebola Virus Infection among Western Healthcare Workers Unable to Recall the Transmission Route”

by Mark G. Kortepeter, Theodore J. Cieslak, Elena H. Kwon, Philip W. Smith, Christopher J. Kratochvil, Angela L. Hewlett
Published 2017-01-01

Managing Potential Laboratory Exposure to Ebola Virus by Using a Patient Biocontainment Care Unit

by Mark G. Kortepeter, James W. Martin, Janice M. Rusnak, Theodore J. Cieslak, Kelly L. Warfield, Edwin L. Anderson, Manmohan V. Ranadive
Published 2008-06-01

Ebola Virus Causes Intestinal Tract Architectural Disruption and Bacterial Invasion in Non-Human Primates

by Ronald B. Reisler, Xiankun Zeng, Christopher W. Schellhase, Jeremy J. Bearss, Travis K. Warren, John C. Trefry, George W. Christopher, Mark G. Kortepeter, Sina Bavari, Anthony P. Cardile
Published 2018-09-01

Health Care Response to CCHF in US Soldier and Nosocomial Transmission to Health Care Providers, Germany, 2009

by Nicholas G. Conger, Kristopher M. Paolino, Erik C. Osborn, Janice M. Rusnak, Stephan Günther, Jane Pool, Pierre E. Rollin, Patrick F. Allan, Jonas Schmidt-Chanasit, Toni Rieger, Mark G. Kortepeter
Published 2015-01-01

Clinical Laboratory Values as Early Indicators of Ebola Virus Infection in Nonhuman Primates

by Ronald B. Reisler, Chenggang Yu, Michael J. Donofrio, Travis K. Warren, Jay B. Wells, Kelly S. Stuthman, Nicole L. Garza, Sean A. Vantongeren, Ginger C. Donnelly, Christopher D. Kane, Mark G. Kortepeter, Sina Bavari, Anthony P. Cardile
Published 2017-08-01

South American Hemorrhagic Fevers: A summary for clinicians

by Maria G. Frank, Adam Beitscher, Camille M. Webb, Vanessa Raabe, Adam Beitscher, Nahid Bhadelia, Theodore J. Cieslak, Richard T. Davey, Kerry Dierberg, Jared D. Evans, Maria G. Frank, Jonathan Grein, Mark G. Kortepeter, Colleen S. Kraft, Chris J. Kratochvil, Karen Martins, Susan McLellan, Aneesh K. Mehta, Vanessa Raabe, George Risi, Lauren Sauer, Erica S. Shenoy, Tim Uyeki
Published 2021-04-01

Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A.

by Michele D Spring, James F Cummings, Christian F Ockenhouse, Sheetij Dutta, Randall Reidler, Evelina Angov, Elke Bergmann-Leitner, V Ann Stewart, Stacey Bittner, Laure Juompan, Mark G Kortepeter, Robin Nielsen, Urszula Krzych, Ev Tierney, Lisa A Ware, Megan Dowler, Cornelus C Hermsen, Robert W Sauerwein, Sake J de Vlas, Opokua Ofori-Anyinam, David E Lanar, Jack L Williams, Kent E Kester, Kathryn Tucker, Meng Shi, Elissa Malkin, Carole Long, Carter L Diggs, Lorraine Soisson, Marie-Claude Dubois, W Ripley Ballou, Joe Cohen, D Gray Heppner
Published 2009-01-01